2004
DOI: 10.1021/bk-2004-0879.ch003
|View full text |Cite
|
Sign up to set email alerts
|

Proniosome-Derived Niosomes for the Delivery of Poorly Soluble Drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2014
2014
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…5 The limitations of phospholipid-based liposomes as drug delivery systems (hydrolysis and oxidative degradation) prompted investigations on using vesicles of other amphiphilic substances, e.g., polymers and surfactants. [6][7][8][9] Vesicles also act as a transdermal drug solubilization systems; this application reduces the toxicity and enhances the skin permeation of the drug. 10 Vesicles prepared from cationic surfactants have advantages over liposomes and non-ionic surfactants (niosomes), because their formulation is simple and their chemical stability against hydrolytic and oxidative degradation in aqueous medium is high.…”
Section: Introductionmentioning
confidence: 99%
“…5 The limitations of phospholipid-based liposomes as drug delivery systems (hydrolysis and oxidative degradation) prompted investigations on using vesicles of other amphiphilic substances, e.g., polymers and surfactants. [6][7][8][9] Vesicles also act as a transdermal drug solubilization systems; this application reduces the toxicity and enhances the skin permeation of the drug. 10 Vesicles prepared from cationic surfactants have advantages over liposomes and non-ionic surfactants (niosomes), because their formulation is simple and their chemical stability against hydrolytic and oxidative degradation in aqueous medium is high.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the search for new supramolecular vesicles of alternative substances is a long-standing topic of research. The past few years have witnessed a significant drug delivery shift in the biomedical arena by developing various new nonphospholipid vesicular systems composed of common surfactants and polymers. …”
Section: Introductionmentioning
confidence: 99%